Jacobs Levy Equity Management’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$150K Buy
2022
Q1
Sell
2021
Q4
$952K Buy
2020
Q4
Sell
2020
Q3
$727K Sell
2020
Q2
$643K Buy